CN1546147A - Effervescence tablet for treating children's cough and asthma and its preparation - Google Patents

Effervescence tablet for treating children's cough and asthma and its preparation Download PDF

Info

Publication number
CN1546147A
CN1546147A CNA2003101191169A CN200310119116A CN1546147A CN 1546147 A CN1546147 A CN 1546147A CN A2003101191169 A CNA2003101191169 A CN A2003101191169A CN 200310119116 A CN200310119116 A CN 200310119116A CN 1546147 A CN1546147 A CN 1546147A
Authority
CN
China
Prior art keywords
concentrated
spent
night
filter
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2003101191169A
Other languages
Chinese (zh)
Other versions
CN1237998C (en
Inventor
潘英宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Aoda Pharmaceutical Co ltd
Original Assignee
YINGKOU AODA PHARMACY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YINGKOU AODA PHARMACY CO Ltd filed Critical YINGKOU AODA PHARMACY CO Ltd
Priority to CN 200310119116 priority Critical patent/CN1237998C/en
Publication of CN1546147A publication Critical patent/CN1546147A/en
Application granted granted Critical
Publication of CN1237998C publication Critical patent/CN1237998C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

A children's cough relieving effervescent tablet and preparation process, the preparation is prepared from Chinese ephedra, honeysuckle flower, bitter apricot seed, isatic root, gupse, licorice root, and pericarpium trichosanthis through the steps of water grilling, alcohol separating, cold storage, centrifuging, charging Chinese ephedra, extracting concrete, drying and disintegrating, granulation, drying and tabletting.

Description

Infantile asthma effervescent tablet and preparation method thereof
Technical field: the present invention relates to a kind of Chinese medicine, especially relate to infantile asthma effervescent tablet of a kind of child's of treatment tracheitis, cough, upper respiratory tract infection and preparation method thereof.
Background technology: tracheitis, cough, upper respiratory tract infection are usual diseases of childhood, frequently-occurring disease, also be anxious, the serious symptom of department of pediatrics in clinical, at present, the Chinese medicine of treatment children with tracheal inflammation, cough, upper respiratory tract infection is generally oral liquid, because the extraction process of oral liquid is that simple water is carried, spissated method is prepared from, the finished product precipitation is many, and the loss of effective components of medicine is bigger when refining, affects the treatment, transport in addition, carry equal inconvenience, limited clinical practice.
Summary of the invention: in order to solve the problem of above-mentioned existence, it is good to the invention provides a kind of therapeutic effect, taking convenience, steady quality, and transportation, infantile asthma effervescent tablet easy to carry and preparation method thereof.
Concrete technical scheme is as follows: a kind of infantile asthma effervescent tablet and preparation method thereof is characterized in that: made by weight by following raw materials of effective components:
Herba Ephedrae 0.5-1.5 Flos Lonicerae 5-15 Semen Armeniacae Amarum 1-9
Radix Isatidis 5-15 Gypsum Fibrosum 10-20 Radix Glycyrrhizae 1-9
Fructus Trichosanthis 1-9;
Preparation method:
Above seven flavor medicine, Herba Ephedrae add 6 times of amount 80% ethanol, reflux, extract, 3 times, each 2 hours, filter merging filtrate, placement is spent the night, and filters filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.05-1.06, add the hydrochloric acid solution of 4 times of amounts 0.1% of medicinal liquid while hot, stir well, cold preservation is spent the night, filter, filtrate is regulated pH value near neutral with ammonia, and cold preservation is spent the night, filter filtrate for later use; Other gets Gypsum Fibrosum, after decocting with water half an hour, add Flos Lonicerae again, Semen Armeniacae Amarum, Radix Isatidis, Fructus Trichosanthis, Radix Glycyrrhizae decocts each 1 hour 3 times, amount of water is 10 times of medical material amount, filter, collecting decoction, relative density is 1.05-1.06 when being concentrated into 60 ℃ of surveys, high speed centrifugation under 150000rpm, it is 1.10-1.12 that centrifugal liquid continues to be concentrated into 60 ℃ of relative densities when surveying, and adds ethanol and makes and contain the alcohol amount and reach 65%, and placement is spent the night, filter, filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.03-1.05 adds the water of 3 times of amounts of medicinal liquid, stirs evenly, cold preservation is spent the night, high speed centrifugation under 150000rpm, the extracting solution of centrifugal liquid and above-mentioned Herba Ephedrae merges, and relative density is the thick paste of 1.20-1.25 when continuing to be concentrated into 60 ℃ of surveys, drying under reduced pressure is ground into fine powder; Get above-mentioned dried cream powder, add the tartaric acid of equivalent and the sodium bicarbonate of equivalent, and Aspartane 30 restrains, xylitol is an amount of, mixing is with dehydrated alcohol granulation, dry, tabletting, promptly.
The present invention has carried out independent extraction with the monarch drug Herba Ephedrae, all the other still adopt decocting, collecting decoction is concentrated into the relative density of regulation, precipitate with ethanol, cold preservation, centrifugal, centrifugal liquid is concentrated into behind the thick paste water precipitating again, improving final preparation clarity, be condensed into after centrifugal and add Herba Ephedrae behind the thick paste and extract extractum, be ground into fine powder behind the vacuum drying, make granule with auxiliary materials and mixing again, drying, tabletting promptly, effervescent is dissolved in hot water but the present invention both has, but effervescent is dissolved in the advantage of directly taking behind the cold water again, be suitable for child administration, simultaneously again because it is a solid preparation, transportation, easy to carry, steady quality, increased content of effective after the process modification, improved curative effect, it is big to have overcome former preparation loss of effective components, the finished product precipitation is many, preserves, carry the shortcoming of inconvenience.
Epheday intermedia of the present invention mainly contains alkaloids composition and volatile oil compositions such as ephedrine, pseudoephedrine, ephedine, L-N methylephedrine, d-N-methyl pseudoephedrine, L-demethyl ephedrine, d-demethyl pseudoephedrine; In addition, also contain compositions such as flavonoid, organic acid, catechu matter; Wherein to be that the main effective ingredient of Herba Ephedrae has analgesic, antiinflammatory, the antitussive effect of relievining asthma for alkaloids composition such as ephedrine and volatile oil composition; Because of volatile oil content is low, be difficult to propose, so extraction process is many to consider alkaloid extraction; The extracting method that Herba Ephedrae alkaloid is commonly used has sour water lixiviate, sour water percolation, alcohol reflux, decocting to boil etc., is the quality of each extraction process relatively, with above-mentioned four kinds of main methods Herba Ephedrae has been carried out extracting relatively respectively, sees Table 1:
Different Extraction Method is extracted the ephedrine tables of data
Extracting method Paste-forming rate (%) Ephedrine hydrochloride content (mg/g Herba Ephedrae)
The sour water lixiviate ????18.77 ????9.40
The sour water percolation ????15.50 ????8.22
Alcohol reflux ????16.83 ????10.25
Decocting boils ????19.33 ????8.35
As shown in Table 2, the highest with the ethanol refluxing process Determination of Ephedrine Hydrochloride, and paste-forming rate is lower.
Other drug:
Flos Lonicerae: main effective ingredient is organic acids such as chlorogenic acid, and water-soluble, Yi Shui carries.
Semen Armeniacae Amarum: mainly contain compositions such as amygdaloside and enzyme, fatty acid, volatile oil, aminoacid; Wherein amygdaloside is the effective ingredient of antitussive and antiasthmatic, and is soluble in water, and suitable decocting extracts.
Gypsum Fibrosum: main component is a hydrous calcium sulfate, still contains Celiang elementses such as titanium, copper, ferrum, aluminum, silicomanganese in addition, and Organic substance, sulfide etc.; The Gypsum Fibrosum decocting liquid causes that to Typhoid Vaccine fever in rabbit has certain antipyretic effect, and tradition is decocted first with Gypsum Fibrosum during clinical practice, reenters other medicines with frying in shallow oil, so should the decocting extraction and be decocted first.
Radix Glycyrrhizae: mainly contain triterpene saponin constituents such as glycyrrhizic acid, enoxolone, and compositions such as flavonoid, alkaloids, polysaccharide, how water-soluble, suitable decocting extracts.
Radix Isatidis: mainly contain indigo, indirubin (but amount is seldom), and some water soluble ingredients.Its decocting liquid has bacteriostasis to staphylococcus aureus, can suppress its proliferation function of the viral infection and the criminal of having system again; So suitable decocting extracts.
Fructus Trichosanthis: mainly contain the triterpene saponin constituents, water-soluble, Yi Shui carries.
In sum, above-mentioned 6 flavor medicines should mix decocting and extract, and wherein Gypsum Fibrosum should be decocted first half an hour.
The preparation stability experiment:
It is 75% calorstat that the effervescent tablet of two aluminum laminated films packing is placed 40 ℃, relative humidity, places 1 month, takes out, and measures appearance character, effervescent time and pH value variation before and after its test, the results are shown in Table 2:
Table 1: comparing result before and after the accelerated test
Sample Appearance character The effervescent time PH value
Before the test Brown tablet 5 minutes 15 seconds 4.1
After the test Brown tablet 5 minutes 08 second 4.0
The result shows: this medicine has no significant change at aspects such as appearance color, physical behavior, effervescent time and pH values before and after the accelerated test, illustrates that this medicine is basicly stable, and moulding process is reasonable.
Acute toxicity test:
With 3.8 crude drugs/ml concentration, 0.4ml/10g volume gastric infusion, 2 times on the one. accumulated dose is 304g crude drug/kg, is equivalent to 238 times of clinical consumption. observed 7 days, mice all survives, and does not see the overt toxicity reaction.
Long term toxicity test:
Rat is irritated stomach respectively and gives infantile asthma effervescent tablet 94.35,47.175,23.5875g/kg (be equivalent to human dosage 74,27,18.5 times), and continuous 90 days, to observe 14 days after the drug withdrawal, rat all survives, and does not see the overt toxicity reaction.
Antivirus test: the big or middle dosage group of infantile asthma effervescent tablet and oral liquid causes that to the influenza virus infecting mouse pneumonia all has the obvious suppression effect, and the lung exponential quantity obviously reduces.
Bacteriostasis: infantile asthma effervescent tablet and oral liquid all have in various degree inhibitory action to six kinds of antibacterial 19 strain bacterial strains such as examination streptococcus pneumoniae.The heavy dose of group of effervescent tablet can make the golden Portugal of infection bacterium mortality of mice obviously reduce, and the effervescent tablet bacteriostasis is better than oral liquid.
Antitussive action: infantile asthma effervescence tablet and oral liquid all can reduce strong aqua ammonia, citric acid causes mice and guinea pig cough's reaction times and prolongs cough latent period, and prompting has antitussive effect.
Phlegm-dispelling functions: infantile asthma effervescence tablet and oral liquid all can increase phenol red output in the mice trachea, and prompting has certain phlegm-dispelling functions.
Antiinflammatory action: infantile asthma effervescence tablet and oral liquid all can suppress HAC and cause the effect that capillary permeability increases, and prompting has antiinflammatory action.
Refrigeration function: infantile asthma effervescence tablet and oral liquid have tangible refrigeration function to yeast pyrogenicity rat.
The present invention has summed up kinds of Diseases and curative effect and following relation was arranged between the course of treatment through clinical practice, sees Table 3, table 4:
Kinds of Diseases and therapeutic effect relationship
Disease Case load Recovery from illness Remarkable result Invalid Effective percentage
Upper respiratory tract infection 100 ?80 ?20 ?0 ?100%
Acute bronchitis 80 ?50 ?26 ?4 ?95%
Pneumonia 50 ?25 ?23 ?2 ?96%
Cough 50 ?27 ?21 ?2 ?96%
Kinds of Diseases and the course of treatment relation
Disease Case load Healing time
One week Two weeks Three weeks All around
Upper respiratory tract infection 100 ?20 ?50 ?30
Acute bronchitis 80 ?5 ?20 ?40 ?11
Pneumonia 50 ?20 ?10 ?18
Cough 50 ?20 ?20 ?8
Usage and consumption:
Two years old with interior one time 1; Three to four years old one time 1.5; Five to seven years old one time 2; 3-4 time on the one, every 1.5g; Be two weeks 1 course of treatment.
Curative effect judging standard:
Recovery from illness: do not have heating, do not have cough, no expectorant, the symptom of relievining asthma;
Produce effects: heating, cough, expectorant, asthma obviously alleviate.
Invalid: as to continue the symptom that heating arranged, cough, have expectorant, asthma.
The specific embodiment:
Embodiment 1: a kind of infantile asthma effervescent tablet and preparation method thereof, make by following raw materials of effective components: (by the gram number)
Herba Ephedrae 62.5g Flos Lonicerae 625g Semen Armeniacae Amarum 312.5g
Radix Isatidis 625g Gypsum Fibrosum 937.5g Radix Glycyrrhizae 312.5g
Fructus Trichosanthis 312.5g;
Preparation method:
Above seven flavor medicine, Herba Ephedrae add 6 times of amount 80% ethanol, reflux, extract, 3 times, each 2 hours, filter merging filtrate, placement is spent the night, and filters filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.05-1.06, add the hydrochloric acid solution of 4 times of amounts 0.1% of medicinal liquid while hot, stir well, cold preservation is spent the night, filter, filtrate is regulated pH value near neutral with ammonia, and cold preservation is spent the night, filter filtrate for later use; Other gets Gypsum Fibrosum, after decocting with water half an hour, add Flos Lonicerae again, Semen Armeniacae Amarum, Radix Isatidis, Fructus Trichosanthis, Radix Glycyrrhizae decocts each 1 hour 3 times, amount of water is 10 times of medical material amount, filter, collecting decoction, relative density is 1.05-1.06 when being concentrated into 60 ℃ of surveys, high speed centrifugation under 150000rpm, it is 1.10-1.12 that centrifugal liquid continues to be concentrated into 60 ℃ of relative densities when surveying, and adds ethanol and makes and contain the alcohol amount and reach 65%, and placement is spent the night, filter, filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.03-1.05 adds the water of 3 times of amounts of medicinal liquid, stirs evenly, cold preservation is spent the night, high speed centrifugation under 150000rpm, the extracting solution of centrifugal liquid and above-mentioned Herba Ephedrae merges, and relative density is the thick paste of 1.20-1.25 when continuing to be concentrated into 60 ℃ of surveys, drying under reduced pressure is ground into fine powder; Get above-mentioned dried cream powder, add the tartaric acid of equivalent and the sodium bicarbonate of equivalent, and Aspartane 30 restrains, xylitol is an amount of, mixing is with dehydrated alcohol granulation, dry, tabletting, promptly.Make 1000 of effervescent tablets altogether.
Embodiment 2: a kind of infantile asthma effervescent tablet and preparation method thereof, make by following raw materials of effective components: (by the gram number)
Herba Ephedrae 62.5g Flos Lonicerae 500g Semen Armeniacae Amarum 250g
Radix Isatidis 562.5g Gypsum Fibrosum 875g Radix Glycyrrhizae 250g
Fructus Trichosanthis 250g;
Preparation method is with embodiment 1.
Embodiment 3: a kind of infantile asthma effervescent tablet and preparation method thereof, make by following raw materials of effective components: (by the gram number)
Herba Ephedrae 62.5g Flos Lonicerae 438g Semen Armeniacae Amarum 188g
Radix Isatidis 438g Gypsum Fibrosum 750g Radix Glycyrrhizae 188g
Fructus Trichosanthis 188g;
Preparation method is with embodiment 1.
Embodiment 4: a kind of infantile asthma effervescent tablet and preparation method thereof, make by following raw materials of effective components: (by the gram number)
Herba Ephedrae 50g Flos Lonicerae 450g Semen Armeniacae Amarum 200g
Radix Isatidis 450g Gypsum Fibrosum 750g Radix Glycyrrhizae 200g
Fructus Trichosanthis 200g;
Preparation method is with embodiment 1.
Embodiment 5: a kind of infantile asthma effervescent tablet and preparation method thereof, make by following raw materials of effective components: (by the gram number)
Herba Ephedrae 40g Flos Lonicerae 320g Semen Armeniacae Amarum 120g
Radix Isatidis 360g Gypsum Fibrosum 400g Radix Glycyrrhizae 120g
Fructus Trichosanthis 120g;
Preparation method is with embodiment 1.

Claims (1)

1, a kind of infantile asthma effervescent tablet is characterized in that: made by weight by following raw materials of effective components:
Herba Ephedrae 0.5-1.5 Flos Lonicerae 5-15 Semen Armeniacae Amarum 1-9
Radix Isatidis 5-15 Gypsum Fibrosum 10-20 Radix Glycyrrhizae 1-9
Fructus Trichosanthis 1-9;
Preparation method:
Above seven flavor medicine, Herba Ephedrae add 6 times of amount 80% ethanol, reflux, extract, 3 times, each 2 hours, filter merging filtrate, placement is spent the night, and filters filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.05-1.06, add the hydrochloric acid solution of 4 times of amounts 0.1% of medicinal liquid while hot, stir well, cold preservation is spent the night, filter, filtrate is regulated pH value near neutral with ammonia, and cold preservation is spent the night, filter filtrate for later use; Other gets Gypsum Fibrosum, after decocting with water half an hour, add Flos Lonicerae again, Semen Armeniacae Amarum, Radix Isatidis, Fructus Trichosanthis, Radix Glycyrrhizae decocts each 1 hour 3 times, amount of water is 10 times of medical material amount, filter, collecting decoction, relative density is 1.05-1.06 when being concentrated into 60 ℃ of surveys, high speed centrifugation under 150000rpm, it is 1.10-1.12 that centrifugal liquid continues to be concentrated into 60 ℃ of relative densities when surveying, and adds ethanol and makes and contain the alcohol amount and reach 65%, and placement is spent the night, filter, filtrate recycling ethanol and to be concentrated into 60 ℃ of relative densities when surveying be 1.03-1.05 adds the water of 3 times of amounts of medicinal liquid, stirs evenly, cold preservation is spent the night, high speed centrifugation under 150000rpm, the extracting solution of centrifugal liquid and above-mentioned Herba Ephedrae merges, and relative density is the thick paste of 1.20-1.25 when continuing to be concentrated into 60 ℃ of surveys, drying under reduced pressure is ground into fine powder; Get above-mentioned dried cream powder, add the tartaric acid of equivalent and the sodium bicarbonate of equivalent, and Aspartane 30 restrains, xylitol is an amount of, mixing is with dehydrated alcohol granulation, dry, tabletting, promptly.
CN 200310119116 2003-12-16 2003-12-16 Effervescence tablet for treating children's cough and asthma and its preparation Expired - Lifetime CN1237998C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310119116 CN1237998C (en) 2003-12-16 2003-12-16 Effervescence tablet for treating children's cough and asthma and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310119116 CN1237998C (en) 2003-12-16 2003-12-16 Effervescence tablet for treating children's cough and asthma and its preparation

Publications (2)

Publication Number Publication Date
CN1546147A true CN1546147A (en) 2004-11-17
CN1237998C CN1237998C (en) 2006-01-25

Family

ID=34338142

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310119116 Expired - Lifetime CN1237998C (en) 2003-12-16 2003-12-16 Effervescence tablet for treating children's cough and asthma and its preparation

Country Status (1)

Country Link
CN (1) CN1237998C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716246A (en) * 2012-06-18 2012-10-10 荣成市商贸城卫生所 Traditional Chinese medicine composite for treating wind-heat type common cold
CN107773593A (en) * 2016-08-30 2018-03-09 北京盈科瑞创新医药股份有限公司 A kind of infantile heat-clearing and antitussive Neulized inhalation pharmaceutical solutions and preparation method thereof
CN111375039A (en) * 2018-12-29 2020-07-07 康明 Traditional Chinese medicine for treating pediatric pneumonia and preparation method thereof
CN112618612A (en) * 2021-01-05 2021-04-09 海南海力制药有限公司 Traditional Chinese medicine granule for treating infantile cough and asthma and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716246A (en) * 2012-06-18 2012-10-10 荣成市商贸城卫生所 Traditional Chinese medicine composite for treating wind-heat type common cold
CN107773593A (en) * 2016-08-30 2018-03-09 北京盈科瑞创新医药股份有限公司 A kind of infantile heat-clearing and antitussive Neulized inhalation pharmaceutical solutions and preparation method thereof
CN111375039A (en) * 2018-12-29 2020-07-07 康明 Traditional Chinese medicine for treating pediatric pneumonia and preparation method thereof
CN112618612A (en) * 2021-01-05 2021-04-09 海南海力制药有限公司 Traditional Chinese medicine granule for treating infantile cough and asthma and preparation method thereof

Also Published As

Publication number Publication date
CN1237998C (en) 2006-01-25

Similar Documents

Publication Publication Date Title
CN101049424A (en) Medication for treating infection in respiratory system
US6916494B2 (en) Anti-hemorrhoid composition and process for its manufacture
CN1425447A (en) Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method
CN1237998C (en) Effervescence tablet for treating children's cough and asthma and its preparation
US7641921B1 (en) Anti-anal fistula composition and process for its manufacture
CN1290544C (en) Medicine for treating acute and chronic hepatitis
WO2011016652A2 (en) Composition for controlling anal fistulae and method for preparing same
CN1686424A (en) Medicinal composition containing scutellaria and bupleurum and its preparation method
CN1073439C (en) Medicine for treating trachitis and asthma and its preparation
CN102274428B (en) Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof
CN102949681B (en) Composition for preventing or treating colds, and its preparation method
CN1939499A (en) Jixiangcao extract, its preparation, medicinal composition and use
CN114601807B (en) Preparation method of fritillaria lung-clearing concentrated pills
CN1101559A (en) Traditional Chinese medicine oral administration liquid for anti-cancer and its preparing method
CN115364169B (en) Chinese medicinal composition for resisting helicobacter pylori, and preparation method and application thereof
CN102429946B (en) Chinese medicinal composition for preparing anti-influenza virus medicament
CN1883654A (en) Pulse invigorating injection with astragalus root and preparation process thereof
CN107412677B (en) Millettia speciosa tea bag and preparation method thereof
CN106377651A (en) Preparation method for extracting pharmaceutical monomer for preventing and treating hyperuricemia and gout from rhizoma smilacis glabrae
CN1403129A (en) Chinese medicine prepn for stopping drug addiction
CN1876075A (en) A medicine for treating asthma, acute and chronic bronchitis and preparation method thereof
CN1259938C (en) Chinese medicine compound preparation for treating cough and its preparing method
CN100335111C (en) Medicine for rheumatism and its preparation
CN1194748C (en) Medicine for treating hypertension and preparation method
CN117530437A (en) Medicine and food dual purpose composition for preventing and treating alcoholic liver injury and its manufacturing method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: LIAONING AODA PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: YINGKOU AODA PHARMACEUTICAL CO.,LTD

CP01 Change in the name or title of a patent holder

Address after: Lunan hi tech Industrial Development Zone, Yingkou, Liaoning, Yingkou

Patentee after: LIAONING AODA PHARMACEUTICAL Co.,Ltd.

Address before: Lunan hi tech Industrial Development Zone, Yingkou, Liaoning, Yingkou

Patentee before: Yingkou Aoda Pharmaceutical Co.,Ltd.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20060125